| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2880324 | The Annals of Thoracic Surgery | 2009 | 7 Pages |
Abstract
SCH appears to influence the postoperative outcome for patients by increasing the development of postoperative atrial fibrillation. However, it is still unproven whether preoperative thyroxine replacement therapy for patients with SCH might prevent postoperative atrial fibrillation after CABG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Young Joo MD, PhD, Ji Won MD, Kwang Il MD, PhD, You Jin MD, PhD, Kyung Won MD, PhD, Sung Hee MD, PhD, Soo MD, PhD, Dong Ju MD, PhD, Kay-Hyun MD, PhD, Joong Haeng MD, PhD, Hak Chul MD, PhD, Seong Yeon MD, PhD, Bo Youn MD, PhD, Cheong MD, PhD,